Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint, Inc. (AVPT) reported that Chief Executive Officer and director Tianyi Jiang had 2,914 shares of common stock withheld on September 11, 2026 to satisfy income tax obligations related to the vesting or settlement of equity awards, an exempt transaction under Rule 16b-3. After this withholding, he holds 2,244,311 shares of common stock, including both non-RSU shares and vested and unvested restricted stock units granted under AvePoint’s 2021 Equity Incentive Plan.
AvePoint, Inc. (AVPT) reported that Executive Chairman and director Gong Xunkai had 3,137 shares of common stock withheld on September 11, 2026 to pay exercise price or tax liability in connection with RSU vesting under the 2021 Equity Incentive Plan, an exempt, non-discretionary transaction. After this withholding, he holds 1,861,171 shares of common stock and RSUs in total.
AvePoint, Inc. (AVPT) reported that Chief Financial Officer Caci James had shares of Common Stock withheld in two exempt transactions to cover tax obligations tied to equity awards. On September 11, 2026, 6,120 shares were withheld at $12.66 per share, and on September 14, 2026, 2,517 shares were withheld at $13.60 per share. Footnotes state these dispositions were for the issuer’s income tax withholding and remittance obligations in connection with net settlement of restricted stock units and do not represent discretionary trades, and that the holdings include both non-RSU common stock and vested and unvested RSUs granted under the 2021 Equity Incentive Plan. No Rule 10b5-1 trading plan is reported.
AvePoint, Inc. (AVPT) reported that Chief Legal Officer and director Brian Michael Brown had company shares withheld in connection with equity compensation vesting. On September 11, 2026, 5,010 shares of common stock were withheld at $12.66 per share, and on September 14, 2026, 1,875 shares were withheld at $13.60 per share. According to the disclosure, these exempt transactions satisfied exercise price or income tax withholding obligations through net settlement under Rule 16b-3 and did not represent discretionary open‑market sales by Brown.
AvePoint, Inc. (AVPT) director and Chief Executive Officer Tianyi Jiang reported two exempt transactions on September 4, 2026, in which a total of 4,390 shares of common stock were disposed of to pay exercise price or tax liability by delivering or withholding securities in connection with vested equity awards. Footnotes state the shares were withheld by AvePoint to satisfy income tax withholding and remittance obligations in a net settlement under the 2021 Equity Incentive Plan and do not represent discretionary market transactions. No Rule 10b5-1 trading plan is reported.
AvePoint, Inc. (AVPT) reported that Executive Chairman Gong Xunkai had a total of 4,724 shares of common stock withheld on September 4, 2026 in two exempt transactions. These code F transactions were shares withheld to pay exercise price or income tax liabilities upon vesting or settlement of awards under the 2021 Equity Incentive Plan, and are not described as discretionary sales.
AvePoint, Inc. (AVPT) reported that its Chief Financial Officer, Caci James, had a total of 5,714 shares of common stock withheld on September 4, 2026 to satisfy tax obligations related to equity vesting. The company states these were exempt transactions under Rule 16b-3 and not discretionary trades by the executive.
AvePoint, Inc. (AVPT) disclosed that Chief Legal Officer and director Brian Michael Brown had 4,092 shares of common stock withheld on September 4, 2026 at $13.43 per share. These shares were withheld solely to pay exercise price or income tax liabilities in connection with RSU-related equity vesting under the 2021 Equity Incentive Plan, as an exempt, non-discretionary transaction, and no Rule 10b5-1 trading plan is reported.
AvePoint, Inc. (AVPT) reported that Chief Executive Officer and director Tianyi Jiang made a bona fide charitable gift of 36,000 shares of Common Stock on September 1, 2026, to Cornell University. This exempt gift is the third of five annual gifts scheduled through June 30, 2028, each in an amount not less than $400,000. Following the gift, Jiang holds 2,251,615 shares of AvePoint common stock, including both non-RSU shares and vested and unvested RSUs granted under the company’s 2021 Equity Incentive Plan. No Rule 10b5-1 trading plan is reported for this transaction.
AvePoint, Inc. (AVPT) director and Chief Legal Officer Brian Michael Brown reported an indirect sale of company common stock held by the Brian M. Brown Revocable Trust. On 2026-08-27, the Trust sold 60,000 shares at $14.20 per share, leaving 384,604 shares held indirectly. The transaction was executed under a Rule 10b5-1 trading plan adopted on 2025-12-16, and Brown disclaims beneficial ownership of the Trust’s shares except to the extent of his pecuniary interest.